New letters urge the Centers for Medicare & Medicaid Services to expand Medicare and Medicaid to include FDA-approved ...
2don MSN
More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...
Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...
Hosted on MSN6h
We Asked Retail Traders About Eli Lilly’s Biggest Post-Q4 Risk — Most Say It’s The Weight-Loss Drug WarsShares of Eli Lilly finished Thursday 3% higher despite an earnings report that showed sales of its blockbuster GLP-1 ...
Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...
2don MSN
CNBC’s Angelica Peebles and Novo Nordisk CEO Lars Fruergaard Jørgensen join 'Squawk Box' to discuss the company's quarterly ...
5don MSNOpinion
In its current form, SNAP operates as a de facto subsidy program that props up some of the unhealthiest parts of the food ...
Tribune News Service on MSN1d
When it comes to heart and brain health, these are numbers you should knowAmerican Heart Association News Heart disease is once again the leading cause of death in the U.S., according to a new statistical report from the American Heart Association. Cardiovascular diseases, ...
Kennedy would need 51 votes in the Senate to be confirmed, but several key Republican lawmakers expressed concerns over his vaccine stance.
As more research is published about the health benefits associated with GLP-1s, like sleep apnea, heart disease, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback